Leonteq Securities’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-1,090
Closed -$7.31K – 1217
2024
Q1
$7.31K Buy
1,090
+470
+76% +$3.72K ﹤0.01% 1041
2023
Q4
$5.65K Buy
+620
New +$3.9K ﹤0.01% 1048

Other funds holding CTKB

Leonteq Securities's CTKB Position: Q2 2024 in Review

Leonteq Securities sold out of Cytek Biosciences (CTKB) in Q2 2024, closing a stake of 1,090 shares — an estimated $7.31K sold.

Leonteq Securities first reported a position in CTKB in Q4 2023 and held it in 2 quarters. The position peaked at $7.31K in Q1 2024. 129 funds tracked by Wall St. Rank hold CTKB as of Q2 2024.

  • Leonteq Securities reported no remaining Cytek Biosciences position as of Q2 2024 after selling out during the quarter.
  • Leonteq Securities sold 1,090 Cytek Biosciences shares in Q2 2024, an estimated $7.31K.
  • Leonteq Securities first reported a position in Cytek Biosciences in Q4 2023 and held it in 2 quarters.
  • Leonteq Securities's Cytek Biosciences position peaked at $7.31K in Q1 2024.
  • 129 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2024.

Based on Leonteq Securities's 13F filing for Q2 2024, filed 4 Mar 2026.